Literature DB >> 21518763

miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kappaB.

Zheng Xu1, Shao-Bo Xiao, Peng Xu, Qian Xie, Lu Cao, Dang Wang, Rui Luo, Yao Zhong, Huan-Chun Chen, Liu-Rong Fang.   

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine that plays a central role in host defense. IL-6 expression can be regulated at both a transcriptional and a post-transcriptional level. We used a combination of bioinformatics and experimental techniques to demonstrate that the miR-365 is a direct negative regulator of IL-6. Overexpression of miR-365 mimics decreased activity of a luciferase reporter containing the IL-6 3'-UTR and led to repression of IL-6 protein. In contrast, ectopic expression of a miR-365 inhibitor elevated IL-6 expression. The negative regulation of miR-365 was strictly dependent on a microRNA binding element in the 3'-UTR of IL-6 mRNA. Deletion mutant analysis of the miR-365 promoter showed that two transcription factors, Sp1 and NF-κB, are essential for the transcriptional regulation of miR-365. We also demonstrate that the MAPK/ERK pathway contributes to the regulation of miR-365. Furthermore, miR-365 exhibited a greater negative regulatory effect on IL-6 than hsa-let-7a, a previously identified microRNA negatively regulating IL-6. Taken together, our results show that miR-365 is a novel negative regulator of IL-6.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518763      PMCID: PMC3122200          DOI: 10.1074/jbc.M110.198630

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 2.  Directing transition from innate to acquired immunity: defining a role for IL-6.

Authors:  Simon A Jones
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

3.  Functional interference of Sp1 and NF-kappaB through the same DNA binding site.

Authors:  F Hirano; H Tanaka; Y Hirano; M Hiramoto; H Handa; I Makino; C Scheidereit
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

Review 4.  Interleukin-6: from basic science to medicine--40 years in immunology.

Authors:  Tadamitsu Kishimoto
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

5.  Structures of zinc finger domains from transcription factor Sp1. Insights into sequence-specific protein-DNA recognition.

Authors:  V A Narayan; R W Kriwacki; J P Caradonna
Journal:  J Biol Chem       Date:  1997-03-21       Impact factor: 5.157

6.  Developmental expression of Sp1 in the mouse.

Authors:  J D Saffer; S P Jackson; M B Annarella
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

7.  Proinflammatory role for let-7 microRNAS in experimental asthma.

Authors:  Sumanth Polikepahad; John M Knight; Arash O Naghavi; Toni Oplt; Chad J Creighton; Chad Shaw; Ashley L Benham; Jong Kim; Benjamin Soibam; R Alan Harris; Cristian Coarfa; Azam Zariff; Aleksandar Milosavljevic; Lakeisha M Batts; Farrah Kheradmand; Preethi H Gunaratne; David B Corry
Journal:  J Biol Chem       Date:  2010-07-14       Impact factor: 5.157

8.  Transcriptional and post-transcriptional regulation of IL-1 beta, IL-6 and TNF-alpha genes in chronic lymphocytic leukaemia.

Authors:  A Rambaldi; S Bettoni; V Rossi; M L Tini; G Giudici; V Rizzo; R Bassan; A Mantovani; T Barbui; A Biondi
Journal:  Br J Haematol       Date:  1993-02       Impact factor: 6.998

9.  A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.

Authors:  N D Perkins; N L Edwards; C S Duckett; A B Agranoff; R M Schmid; G J Nabel
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

10.  Human MicroRNA targets.

Authors:  Bino John; Anton J Enright; Alexei Aravin; Thomas Tuschl; Chris Sander; Debora S Marks
Journal:  PLoS Biol       Date:  2004-10-05       Impact factor: 8.029

View more
  67 in total

1.  MicroRNA-365 regulates the occurrence and immune response of sepsis following multiple trauma via interleukin-6.

Authors:  Hui Gong; Xiaomin Sheng; Jianhua Xue; Dongbo Zhu
Journal:  Exp Ther Med       Date:  2018-08-22       Impact factor: 2.447

2.  MicroRNA 373 Facilitates the Replication of Porcine Reproductive and Respiratory Syndrome Virus by Its Negative Regulation of Type I Interferon Induction.

Authors:  Jing Chen; Xibao Shi; Xiaozhuan Zhang; Aiping Wang; Li Wang; Yanyan Yang; Ruiguang Deng; Gai-Ping Zhang
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

3.  MicroRNA-365 in macrophages regulates Mycobacterium tuberculosis-induced active pulmonary tuberculosis via interleukin-6.

Authors:  Qingzhang Song; Hui Li; Hua Shao; Chunling Li; Xiao Lu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  MiR-365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4.

Authors:  Ying-Jie Guan; Xu Yang; Lei Wei; Qian Chen
Journal:  FASEB J       Date:  2011-08-19       Impact factor: 5.191

5.  The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis.

Authors:  Akbar Ahmad; Juliana de Camargo Vieira; Aline Haas de Mello; Thais Martins de Lima; Suely Kubo Ariga; Denise Frediani Barbeiro; Hermes Vieira Barbeiro; Bartosz Szczesny; Gábor Törö; Nadiya Druzhyna; Elisa B Randi; Michela Marcatti; Tracy Toliver-Kinsky; András Kiss; Lucas Liaudet; Reinaldo Salomao; Francisco Garcia Soriano; Csaba Szabo
Journal:  Pharmacol Res       Date:  2019-05-06       Impact factor: 7.658

Review 6.  Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.

Authors:  Aline Cristina Targa Cadamuro; Ana Flávia Teixeira Rossi; Nathália Maciel Maniezzo; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

7.  p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.

Authors:  Bangxing Hong; Haiyan Li; Mingjun Zhang; Jingda Xu; Yong Lu; Yuhuan Zheng; Jianfei Qian; Jeffrey T Chang; Jing Yang; Qing Yi
Journal:  Int J Cancer       Date:  2014-05-16       Impact factor: 7.396

Review 8.  Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver Disease.

Authors:  Elise Slevin; Leonardo Baiocchi; Nan Wu; Burcin Ekser; Keisaku Sato; Emily Lin; Ludovica Ceci; Lixian Chen; Sugeily R Lorenzo; Wenjuan Xu; Konstantina Kyritsi; Victoria Meadows; Tianhao Zhou; Debiyoti Kundu; Yuyan Han; Lindsey Kennedy; Shannon Glaser; Heather Francis; Gianfranco Alpini; Fanyin Meng
Journal:  Am J Pathol       Date:  2020-09-11       Impact factor: 4.307

9.  Isoflurane and sevoflurane increase interleukin-6 levels through the nuclear factor-kappa B pathway in neuroglioma cells.

Authors:  L Zhang; J Zhang; L Yang; Y Dong; Y Zhang; Z Xie
Journal:  Br J Anaesth       Date:  2013-04-19       Impact factor: 9.166

10.  Control of early Theiler's murine encephalomyelitis virus replication in macrophages by interleukin-6 occurs in conjunction with STAT1 activation and nitric oxide production.

Authors:  Tyler C Moore; Katherine L Bush; Liz Cody; Deborah M Brown; Thomas M Petro
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.